Brandon Latifi
University of California, Irvine(US)UC Irvine Health(US)
Publications by Year
Research Areas
Advanced biosensing and bioanalysis techniques, RNA and protein synthesis mechanisms, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Click Chemistry and Applications
Most-Cited Works
- → Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity(2019)185 cited
- → Self-cleaving ribozymes: substrate specificity and synthetic biology applications(2021)44 cited
- → Prediction of Human Pharmacokinetics of Antibody–Drug Conjugates From Nonclinical Data(2019)28 cited
- → Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody–Drug Conjugates(2018)23 cited
- → Front Cover: Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity (ChemMedChem 1/2020)(2020)22 cited
- → Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemia(2018)18 cited
- → Protection of nuclear DNA by lifespan-extending compounds in the yeast Saccharomyces cerevisiae(2021)7 cited
- → Anti–Lymphocyte Antigen 6 Complex, Locus E-Seco-Cyclopropabenzindol-4-One-Dimer Antibody-Drug Conjugate That Forms Adduct with α1-Microglobulin Demonstrates Slower Systemic Antibody Clearance and Reduced Tumor Distribution in Animals(2020)4 cited
- → In vitro selection of human cerebrospinal fluid-specific aptamers using clinical samples(2024)3 cited
- → Accurate Detection of Cerebrospinal Fluid by DNA Aptamers Derived by Clinical Samples(2025)2 cited